Shun Lu Selected Research

Shun Lu Research Topics

Disease

164	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 02/2007
127	Neoplasms (Cancer) 05/2024 - 11/2008
66	Lung Neoplasms (Lung Cancer) 05/2024 - 12/2003
32	Disease Progression 05/2024 - 08/2011
26	Neoplasm Metastasis (Metastasis) 12/2023 - 09/2008
22	Adenocarcinoma of Lung 01/2023 - 09/2008
15	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2023 - 08/2015
11	Exanthema (Rash) 11/2022 - 08/2011
10	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2024 - 01/2015
10	Carcinoma (Carcinomatosis) 12/2022 - 11/2018
9	Brain Neoplasms (Brain Tumor) 05/2023 - 11/2015
9	Diarrhea 01/2023 - 01/2017
9	Carcinogenesis 04/2022 - 10/2013
7	Neutropenia 04/2023 - 08/2011
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 01/2020
6	Stomatitis 12/2022 - 02/2014
6	Acne Vulgaris 01/2018 - 02/2014
5	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 11/2013
5	Adenocarcinoma 01/2022 - 11/2008
5	Thrombocytopenia (Thrombopenia) 01/2018 - 09/2008
4	Squamous Cell Carcinoma of Head and Neck 01/2024 - 01/2019
4	Vomiting 01/2023 - 02/2014
4	Pain (Aches) 12/2022 - 01/2015
3	Osteonecrosis (Kienbock's Disease) 11/2023 - 01/2023
3	Inflammation (Inflammations) 11/2023 - 06/2021
3	Hypertriglyceridemia 05/2023 - 11/2018
3	Anemia 04/2023 - 10/2018
3	Drug-Related Side Effects and Adverse Reactions 01/2023 - 06/2012
3	Dyspnea (Shortness of Breath) 03/2022 - 01/2018
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 05/2020
3	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2021 - 05/2012
3	Leukopenia 01/2021 - 07/2010
3	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 01/2015
3	Infections 01/2017 - 01/2010

Drug/Important Bio-Agent (IBA)

43	ErbB Receptors (EGF Receptor)IBA 03/2024 - 04/2009
29	Tyrosine Kinase InhibitorsIBA 01/2024 - 08/2011
24	PlatinumIBA 04/2024 - 06/2009
22	Biomarkers (Surrogate Marker)IBA 01/2024 - 04/2009
20	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2019
18	AfatinibIBA 01/2022 - 02/2014
17	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 02/2014
15	NivolumabIBA 05/2024 - 01/2019
15	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2013
15	Gefitinib (Iressa)FDA Link 10/2023 - 08/2011
14	CrizotinibIBA 12/2023 - 01/2016
13	osimertinibIBA 03/2024 - 01/2018
13	Pemetrexed (MTA)FDA Link 02/2024 - 10/2009
13	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2021 - 08/2011
11	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2013
10	Anaplastic Lymphoma KinaseIBA 08/2022 - 05/2015
9	Docetaxel (Taxotere)FDA Link 04/2024 - 06/2009
9	Gemcitabine FDA Link 01/2019 - 08/2011
8	Phosphotransferases (Kinase)IBA 01/2024 - 05/2015
7	B7-H1 AntigenIBA 11/2023 - 01/2019
7	Carboplatin (JM8)FDA LinkGeneric 11/2023 - 08/2011
6	Small Interfering RNA (siRNA)IBA 11/2023 - 01/2013
6	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 01/2023 - 01/2019
5	IpilimumabIBA 02/2024 - 01/2021
5	Bevacizumab (Avastin)FDA Link 01/2023 - 07/2015
5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 03/2008
5	Alanine Transaminase (SGPT)IBA 11/2022 - 08/2011
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2013
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 04/2009
4	atezolizumabIBA 04/2024 - 01/2021
4	alectinibIBA 04/2024 - 11/2021
4	Messenger RNA (mRNA)IBA 01/2024 - 10/2013
4	Etoposide (VP 16)FDA LinkGeneric 11/2023 - 01/2015
4	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2021
4	selpercatinibIBA 10/2023 - 01/2022
4	LigandsIBA 03/2022 - 01/2013
4	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2006
4	Circulating Tumor DNAIBA 01/2022 - 01/2019
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2019 - 09/2008
4	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 09/2019 - 01/2017
3	InterferonsIBA 05/2024 - 01/2014
3	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2019
3	CytokinesIBA 01/2024 - 01/2015
3	brigatinibIBA 12/2023 - 11/2021
3	tislelizumabIBA 11/2023 - 05/2021
3	Peptides (Polypeptides)IBA 11/2023 - 06/2012
3	Biosimilar PharmaceuticalsIBA 01/2023 - 12/2019
3	sintilimabIBA 01/2023 - 01/2022
3	pyrotinibIBA 01/2022 - 09/2021
3	aumolertinibIBA 01/2022 - 06/2021
3	EnzymesIBA 11/2021 - 05/2011
3	AntibodiesIBA 09/2021 - 12/2019
3	HMPL-013IBA 02/2021 - 01/2018
3	Cell-Free Nucleic AcidsIBA 01/2021 - 01/2017
3	Protein Isoforms (Isoforms)IBA 12/2019 - 12/2013

Therapy/Procedure

73	Drug Therapy (Chemotherapy) 05/2024 - 02/2007
73	Therapeutics 02/2024 - 12/2003
33	Immunotherapy 05/2024 - 06/2018
15	Radiotherapy 04/2024 - 11/2012
5	Adjuvant Chemotherapy 07/2023 - 06/2009
5	Precision Medicine 01/2023 - 01/2017
4	Chemoradiotherapy 01/2023 - 12/2016
4	Neoadjuvant Therapy 01/2023 - 01/2020
3	Oral Administration 11/2023 - 08/2015
3	Lymph Node Excision (Lymph Node Dissection) 11/2022 - 06/2009
3	Pneumonectomy (Lung Volume Reduction) 01/2017 - 06/2009